- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Novartis Launches Tech Prize to Address Unmet MS Community Needs
Novartis-along with WIRED Brand Lab and other collaborators including Techstars, Shift.ms, and the National Multiple Sclerosis Society-has launched the Innovation Prize for Assistive Tech to encourage new technologies that address the unmet needs of the multiple sclerosis community. The Novartis Innovation Prize: Assistive Tech for Multiple Sclerosis (MS) identifies and embraces technology that aims to improve mobility and daily life for people living with MS. Applications are open worldwide to the tech community, innovators, design experts, patient advocates – "anyone with an idea to make everyday life better for those with MS or mobility-limiting disabilities." Applications will be accepted until January 10, 2020 at 17:00 ET and the winners will be announced at the SXSW conference in Austin, Texas on March 13, 2020. In order to develop their innovation, the first-place winner will receive a prize worth $250,000 and the second-place winner will receive $50,000.* *More information can be found at www.wired.com/msinnovationprize
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.
